Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/40602
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Decreased STAMP2 expression in association with visceral adipose tissue dysfunction

AutorMoreno-Navarrete, José Maria; Ortega, Francisco J.; Pérez-Pérez, Rafael CSIC ORCID; Ricart, Wifredo; Peral, Belén CSIC ORCID; Fernández-Real, José M.
Palabras claveSTAMP2
Human obesity
Gene expression
Type 2 diabetes
Fecha de publicación17-ago-2011
EditorEndocrine Society
CitaciónJournal of Clinical Endocrinology and Metabolism 96(11): E1816-E1825 (2011)
Resumen[Context]: Six-transmembrane protein of prostate 2 (STAMP2) is a counter-regulator of inflammation and insulin resistance according to findings in mice. However, there have been contradictory reports in humans. [Objective]: We aimed to explore STAMP2 in association with inflammatory and metabolic status of human obesity. [Design, Patients, and Methods]: STAMP2 gene expression was analyzed in adipose tissue samples (171 visceral and 67 sc depots) and during human preadipocyte differentiation. Human adipocytes were treated with macrophage-conditioned medium, TNF-α, and rosiglitazone. [Results]: In visceral adipose tissue, STAMP2 gene expression was significantly decreased in obese subjects, mainly in obese subjects with type 2 diabetes. STAMP2 gene expression and protein were significantly and inversely associated with obesity phenotype measures (body mass index, waist, hip, and fat mass) and obesity-associated metabolic disturbances (systolic blood pressure and fasting glucose). In addition, STAMP2 gene expression was positively associated with lipogenic (FASN, ACC1, SREBP1, THRSP14, TRα, and TRα1), CAV1, IRS1, GLUT4, and CD206 gene expression. In sc adipose tissue, STAMP2 gene expression was not associated with metabolic parameters. In both fat depots, STAMP2 gene expression in stromovascular cells was significantly higher than in mature adipocytes. STAMP2 gene expression was significantly increased during the differentiation process in parallel to adipogenic genes, being increased in preadipocytes derived from lean subjects. Macrophage-conditioned medium (25%) and TNF-α (100 ng/ml) administration increased whereas rosiglitazone (2 μM) decreased significantly STAMP2 gene expression in human differentiated adipocytes. [Conclusions]: Decreased STAMP2 expression (mRNA and protein) might reflect visceral adipose dysfunction in subjects with obesity and type 2 diabetes.
Descripción10 páginas, 6 figuras, 2 tablas.-- et al.
Versión del editorhttp://dx.doi.org/10.1210/jc.2011-0310
URIhttp://hdl.handle.net/10261/40602
DOI10.1210/jc.2011-0310
ISSN0021-972X
E-ISSN1945-7197
Aparece en las colecciones: (IIBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
JClinEndocrinolMetab_2011_Aug_17.pdf248,7 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

31
checked on 22-abr-2024

WEB OF SCIENCETM
Citations

31
checked on 14-feb-2024

Page view(s)

377
checked on 23-abr-2024

Download(s)

286
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.